Phibro Animal Health (PAHC) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Phibro Animal Health (PAHC) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 20.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.41% |
| Dec 31, 2025 | 54.42% |
| Sep 30, 2025 | 102.39% |
| Jun 30, 2025 | -95.13% |
| Mar 31, 2025 | -1.63% |
| Dec 31, 2024 | -4.82% |
| Sep 30, 2024 | 1,670.09% |
| Jun 30, 2024 | 1,658.67% |
| Mar 31, 2024 | -6.67% |
| Dec 31, 2023 | -19.86% |
| Sep 30, 2023 | -103.47% |
| Jun 30, 2023 | -34.95% |
| Mar 31, 2023 | -38.69% |
| Dec 31, 2022 | -52.37% |
| Sep 30, 2022 | -22.32% |
| Jun 30, 2022 | 41.87% |
| Mar 31, 2022 | 57.56% |
| Dec 31, 2021 | 25.60% |
| Sep 30, 2021 | -5.52% |
| Jun 30, 2021 | -16.97% |